Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Aber H. Baki"'
Publikováno v:
Journal of Nephropharmacology, Vol 11, Iss 1, Pp e5-e5 (2022)
Introduction: Secondary hyperparathyroidism (SHPT) is one of the components of chronic kidney disease–mineral bone disorder (CKD-MBD) with significant contribution to the morbidity and mortality among prevalent hemodialysis (HD) patients. Objective
Externí odkaz:
https://doaj.org/article/8a4ebf413edf4aa9a895d6a4a4301004
Autor:
Aber H. Baki, John K. Zarif
Publikováno v:
The Egyptian Journal of Hospital Medicine. 81:1710-1717
Background: Fenofibrates were not previously known to affect renal function tests until some reports indicated that these drugs may lead to a decrease in renal function. Likewise, the nephrotoxic effect of fibrates remains to be vague and unclear. Gu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65c51693f7970a2c1f23d5b8555c9021
https://doi.org/10.21608/ejhm.2020.118574
https://doi.org/10.21608/ejhm.2020.118574
Publikováno v:
Journal of Nephropharmacology, Vol 11, Iss 1, Pp e5-e5 (2022)
Background Secondary hyperparathyroidism (SHPT) is one of the components of chronic kidney disease–mineral bone disorder (CKD-MBD) with significant contribution to the morbidity and mortality among prevalent hemodialysis (HD) patients. Objectives M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d04a023f650d073cb80cfacab6de623e
https://doi.org/10.1093/qjmed/hcab100.044
https://doi.org/10.1093/qjmed/hcab100.044